The paper is titled "Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial." More information: Jeanne Tie et al ...
In its updated guidelines for colon cancer 1 and for rectal cancer 2 ... Custom-built for each individual, Signatera uses circulating tumor DNA to detect and quantify cancer left in the body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback